A detailed history of Soltis Investment Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Soltis Investment Advisors LLC holds 778 shares of VRTX stock, worth $315,300. This represents 0.04% of its overall portfolio holdings.

Number of Shares
778
Previous 695 11.94%
Holding current value
$315,300
Previous $325,000 11.08%
% of portfolio
0.04%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

BUY
$460.0 - $505.78 $38,180 - $41,979
83 Added 11.94%
778 $361,000
Q2 2024

Aug 12, 2024

BUY
$392.81 - $485.53 $273,002 - $337,443
695 New
695 $325,000
Q2 2022

Aug 11, 2022

BUY
$234.96 - $292.55 $103,617 - $129,014
441 Added 6.54%
7,188 $2.03 Million
Q1 2022

May 06, 2022

BUY
$221.42 - $260.97 $1.49 Million - $1.76 Million
6,747 New
6,747 $1.76 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $104B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Soltis Investment Advisors LLC Portfolio

Follow Soltis Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soltis Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soltis Investment Advisors LLC with notifications on news.